Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS)

CUSIP: 00509G209

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
71,531,081
Total 13F shares
27,496,751
Share change
+1,868,350
Total reported value
$275,793,298
Put/Call ratio
3.3%
Price per share
$10.03
Number of holders
48
Value change
+$19,526,193
Number of buys
30
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 00509G209?
CUSIP 00509G209 identifies ABOS - Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS) as of Q3 2022

As of 30 Sep 2022, Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,496,751 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Deep Track Capital, LP, Sands Capital Ventures, LLC, Laurion Capital Management LP, GREAT POINT PARTNERS LLC, BlackRock Inc., COMMODORE CAPITAL LP, VANGUARD GROUP INC, DRIEHAUS CAPITAL MANAGEMENT LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 48 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.